(Club de Revista 045) En este club de revista se discute la comparación de alopurinol contra febuxostat respecto a riesgo cardiovascular. Revisamos los desenlaces del estudio FAST. ENLACE: https://bit.ly/2ThUkGS
show moreAuthor | MedicCreative |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Browse Spreaker Catalogue to discover great new content
Browse Spreaker Catalogue to discover great new content
It's so quiet here...
Time to discover new episodes!